1348P Efficacy and safety of ceritinib 450 mg-fed vs 750 mg-fasted in Asian patients (pts) with ALK+ non-small cell lung cancer (NSCLC) in the ASCEND-8 trial von Cho, B.C. Chul, Kim, D-W., Batra, U., Park, K., Kim, S-W., Yang, C.T., Jye, V. Pie, Sriuranpong, V., Babu, K.G., Amin, K., Wang, Y., Wang, L., Bhering, M., Geater, S. Lucien

Volltext